Neuro-Degenerative Disease Clinical Trials

9 recruiting

Neuro-Degenerative Disease Trials at a Glance

9 actively recruiting trials for neuro-degenerative disease are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Toronto, Dallas, and San Francisco. Lead sponsors running neuro-degenerative disease studies include University Health Network, Toronto, Chinese University of Hong Kong, and Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer.

Browse neuro-degenerative disease trials by phase

Treatments under study

About Neuro-Degenerative Disease Clinical Trials

Looking for clinical trials for Neuro-Degenerative Disease? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Neuro-Degenerative Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Neuro-Degenerative Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

3D Printers for Autonomy in the Care of Inpatients in Continuing and Rehabilitation Care

Neuro-Degenerative Disease
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer75 enrolled2 locationsNCT07087574
Recruiting

A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J

Peripheral NeuropathyNeuro-Degenerative DiseaseNeuromuscular Diseases
Elpida Therapeutics SPC20 enrolled3 locationsNCT06151600
Recruiting

Persons With Dementia and Their Extended Family Caregivers

DementiaNeuro-Degenerative DiseaseDementia Alzheimers+2 more
Karen Roberto360 enrolled1 locationNCT04863859
Recruiting
Phase 2

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

Langerhan's Cell HistiocytosisJuvenile XanthogranulomaErdheim-Chester Disease+4 more
Carl Allen90 enrolled12 locationsNCT04079179
Recruiting

A Vision-Language Foundation Model for Brain Disease Diagnosis From Multimodal Data

Brain DiseasesNeuro-Degenerative DiseaseBrain (Nervous System) Cancers+3 more
Xiangya Hospital of Central South University100,000 enrolled1 locationNCT07126821
Recruiting

Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.

Metabolic DiseaseNeurologic DisorderRare Diseases+3 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta100 enrolled1 locationNCT04880356
Recruiting
Not Applicable

3T MRI in Patients With Deep Brain Stimulation (DBS)

Neuro-Degenerative Disease
University Health Network, Toronto250 enrolled1 locationNCT03153670
Recruiting

Visualization of Neural Targets With 3T MRI

Neuro-Degenerative Disease
University Health Network, Toronto40 enrolled1 locationNCT05175417
Recruiting

Identifying Biomarkers in Alzheimer's Disease

Neuro-Degenerative DiseaseAlzheimer Disease
Chinese University of Hong Kong300 enrolled1 locationNCT05655650